in connection with a scheme to prescribe Subsys, a potent fentanyl-based spray, in exchange for bribes and kickbacks from the drug's manufacturer, Insys Therapeutics. Jeffrey Goldstein, 49, prescribed his patients Subsys in exchange for close to $200,000 in bribes and kickbacks from the drug's manufacturer, as w

in connection with a scheme to prescribe Subsys, a potent fentanyl-based spray, in exchange for bribes and kickbacks from the drug's manufacturer, Insys Therapeutics. Jeffrey Goldstein, 49, prescribed his patients Subsys in exchange for close to $200,000 in bribes and kickbacks from the drug's manufacturer, as w

nt and testify against his father at trial, and we hope to proffer him in the coming weeks. • Insys (Solowiejczyk/Abramowicz) (USAO # 2015R01751): Insys Therapeutics paid kickbacks to induce doctors to prescribe a fentanyl-based painkiller called Subsys. We indicted five doctors in March 2018, two of whom have s

ed in an indictment returned in U.S. District Court Wednesday of accepting more than $109,000 in kickbacks between 2012 and 2016 from Arizona-based Insys Therapeutics." Prosecutors "said she took sham speaking fees to more broadly prescribe an oral fentanyl spray approved for a specific type of cancer pain." CYB

KEYW IPO's (priced): Qihoo 360 (QIHU) 12.1M shares priced at $14.50, Apollo Global Management (APO) 29.758M shares priced at $19.00 IPO's (filed): Insys Therapeutics (INRX) files $55M through Wells & JMP Key Research: Wells initiates BRKR/GEOI (op's) & WAT (mp), Moke initiates CTXS (op), Soleil initiates HCA (bu